Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis (Scientific Reports, (2020),

Stephen J. McWilliam; Anna Rosala-Hallas; Ashley P. Jones; Victoria Shaw; William Greenhalf; Thomas Jaki; Alan R. Smyth; Rosalind L. Smyth; Munir Pirmohamed

doi:10.1038/s41598-020-61783-9

Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis (Scientific Reports, (2020),

Stephen J. McWilliam^*, Anna Rosala-Hallas, Ashley P. Jones, Victoria Shaw, William Greenhalf, Thomas Jaki, Alan R. Smyth, Rosalind L. Smyth, Munir Pirmohamed

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

5 Downloads (Pure)

Abstract

In this Article, the Competing Interests statement was

Save

omitted. The Competing Interests section should read: “MP has a PhD studentship jointly funded by EPSRC and Astra Zeneca on drug-drug interactions, but this is not specifically focusing on rosuvastatin or other statins”.

Original language	English
Article number	4730
Number of pages	1
Journal	Scientific Reports
Volume	10
Issue number	1
DOIs	https://doi.org/10.1038/s41598-020-61783-9
Publication status	Published - 10 Mar 2020
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2020, The Author(s).

ASJC Scopus subject areas

General

Access to Document

10.1038/s41598-020-61783-9

A randomised controlled trial of rosuvastatin for the prevention of aminoglycosideinduced kidney toxicity in children with cystic fbrosis
© 2023 The Authors. This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
Final published version, 619 KBLicence: CC BY

1 Article

A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis
McWilliam, S. J., Rosala-Hallas, A., Jones, A. P., Shaw, V., Greenhalf, W., Jaki, T., Smyth, A. R., Smyth, R. L. & Pirmohamed, M., 04 Feb 2020, In: Scientific Reports. 10, 9 p., 1796.
Research output: Contribution to journal › Article › peer-review

Open Access
File
6 Citations (Scopus)

5 Downloads (Pure)

Cite this

McWilliam, S. J., Rosala-Hallas, A., Jones, A. P., Shaw, V., Greenhalf, W., Jaki, T., Smyth, A. R., Smyth, R. L., & Pirmohamed, M. (2020). Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis (Scientific Reports, (2020), Scientific Reports, 10(1), Article 4730. https://doi.org/10.1038/s41598-020-61783-9

@article{2f7c0c2942294ddb8afec34af31e7275,

title = "Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis (Scientific Reports, (2020),",

abstract = "In this Article, the Competing Interests statement was Saveomitted. The Competing Interests section should read: “MP has a PhD studentship jointly funded by EPSRC and Astra Zeneca on drug-drug interactions, but this is not specifically focusing on rosuvastatin or other statins”.",

author = "McWilliam, {Stephen J.} and Anna Rosala-Hallas and Jones, {Ashley P.} and Victoria Shaw and William Greenhalf and Thomas Jaki and Smyth, {Alan R.} and Smyth, {Rosalind L.} and Munir Pirmohamed",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = mar,

day = "10",

doi = "10.1038/s41598-020-61783-9",

language = "English",

volume = "10",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Research",

number = "1",

}

McWilliam, SJ, Rosala-Hallas, A, Jones, AP, Shaw, V, Greenhalf, W, Jaki, T, Smyth, AR, Smyth, RL & Pirmohamed, M 2020, 'Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis (Scientific Reports, (2020),', Scientific Reports, vol. 10, no. 1, 4730. https://doi.org/10.1038/s41598-020-61783-9

Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis (Scientific Reports, (2020), / McWilliam, Stephen J.; Rosala-Hallas, Anna; Jones, Ashley P. et al.
In: Scientific Reports, Vol. 10, No. 1, 4730, 10.03.2020.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis (Scientific Reports, (2020),

AU - McWilliam, Stephen J.

AU - Rosala-Hallas, Anna

AU - Jones, Ashley P.

AU - Shaw, Victoria

AU - Greenhalf, William

AU - Jaki, Thomas

AU - Smyth, Alan R.

AU - Smyth, Rosalind L.

AU - Pirmohamed, Munir

PY - 2020/3/10

Y1 - 2020/3/10

N2 - In this Article, the Competing Interests statement was Saveomitted. The Competing Interests section should read: “MP has a PhD studentship jointly funded by EPSRC and Astra Zeneca on drug-drug interactions, but this is not specifically focusing on rosuvastatin or other statins”.

AB - In this Article, the Competing Interests statement was Saveomitted. The Competing Interests section should read: “MP has a PhD studentship jointly funded by EPSRC and Astra Zeneca on drug-drug interactions, but this is not specifically focusing on rosuvastatin or other statins”.

U2 - 10.1038/s41598-020-61783-9

DO - 10.1038/s41598-020-61783-9

M3 - Comment/debate

C2 - 32152372

AN - SCOPUS:85081567387

SN - 2045-2322

VL - 10

JO - Scientific Reports

JF - Scientific Reports

IS - 1

M1 - 4730

ER -

Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis (Scientific Reports, (2020),

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Fingerprint

Research output

A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis

Cite this